Publications

Dinger Jürgen, Nitschmann S, Kardiovaskuläre Auswirkungen hormoneller Kontrazeption Internist. 2013; 54:1520-1522. doi:10.1007/s00108-013-3394-5.

Bardenheuer Kristina, Dinger Jürgen, Do Minh Thai, Venous thromboemolism in users of a 24-day regimen of a combined oral contraceptive compare to conventional 21-day regimens: final results from the INAS-OC study. Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Heinemann Klaas, Dinger Jürgen, Bardenheuer Kristina, Reed Suzanne, The safety of oral contraceptives in adolescents. Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Dinger Jürgen, Möhner Sabine, Heinemann Klaas, Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring. Obstetrics & Gynecology. 2013; 122(4): 800 - 808. 10.1097/AOG.0b013e3182a5ec6b.
Download PDF: Cardiovascular_Risk_Associated_With_the_Use_of_an.11.pdf

Heinemann Klaas, Reed Suzanne, Möhner Sabine, Ectopic pregnancies under IUD use: interim results from the EURAS-IUD study Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Heinemann Klaas, Reed Suzanne, Möhner Sabine, Breastfeeding as as risk factor for uterine preforation during IUD insertion: interim results from the ERUAS-IUD study Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Möhner Sabine, Dinger Jürgen, Heinemann Klaas, Transatlantic active surveillance of cardiovascular safety (TASC) of an Etonogestrel/Ethinylestradiol-containing vaginal ring. Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Dinger Jürgen, M Kieble, Rare serious adverse events: comparison of patient- and physician-reported outcomes. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 732. DOI 10.1002.

Dennerstein L, Lehert P, Heinemann Klaas, Epidemiology of premenstrual symptoms and disorders. Menopause International. 2012; Jun;18(2):48-51.

Heinemann Klaas, Assmann Anita, Dinger Jürgen, The safety of oral hormone replacement therapy: final results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 365. DOI 10.1002.

Reed Suzanne, Bardenheuer Kristina, Dinger Jürgen, VTE risk in users of combined oral contraceptives: impact of a 24-Day regimen containing drospirenone. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 361. DOI 10.1002.

Heinemann Klaas, Assmann Anita, Möhner Sabine, Long term active surveillance study for oral contraceptives (LASS): final results on cardiovascular safety. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 360. DOI 10.1002.

Heinemann Klaas, Reed Suzanne, Dinger Jürgen, Intrauterine devices and risk of uterine perforations: interim results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S2) 45. DOI 10.1002.

Dinger Jürgen, Bardenheuer Kristina, M Kieble, Informationsquellen von seltenen schwerwiegenden Erkrankungen: Arzt oder Patient? . Abstractband der 7. Jahrestagung der Deutschen Gesellschaft für Epidemiologie,. 2012; Sept: 133(P1).

Bardenheuer Kristina, Kern S, Leddin Janko, Unterschiedliches Verschreibungsverhalten der "Pille" bei Jugendlichen und Erwachsenen. . Abstractband der 7. Jahrestagung der Deutschen Gesellschaft für Epidemiologie,. 2012; Sept: 194(P118).